SanBio Co., Ltd. (4592) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

JPY 176,254 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-1.15

Return on Equity

-225.79%

Price to Book

93.01

Revenue and Profits:

Net Sales:

(Quarterly Results - Apr 2025)

Net Profit:

-1,531 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-30.3%

6 Months

-54.0%

1 Year

87.86%

2 Years

242.45%

3 Years

113.55%

4 Years

66.05%

5 Years

-8.1%

SanBio Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-100.00%

EBIT Growth (5y)

6.35%

EBIT to Interest (avg)

-111.21

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.43

Sales to Capital Employed (avg)

Tax Ratio

12.22%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

141.62

EV to EBIT

-70.29

EV to EBITDA

-70.48

EV to Capital Employed

-324.55

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-164.06%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

Mildly Bearish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Apr'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Apr 2025 is 0.00% vs 0.00% in Apr 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Apr 2025 is -957.67% vs 76.88% in Apr 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Apr'25",
        "Apr'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1,005.40",
          "val2": "-664.10",
          "chgp": "-51.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.30",
          "val2": "5.30",
          "chgp": "37.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1,531.50",
          "val2": "-144.80",
          "chgp": "-957.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jan'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jan 2025 is 0.00% vs 0.00% in Jan 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jan 2025 is -9.02% vs 52.44% in Jan 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jan'25",
        "Jan'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3,506.70",
          "val2": "-4,525.20",
          "chgp": "22.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "18.90",
          "val2": "25.80",
          "chgp": "-26.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "9.30",
          "val2": "252.30",
          "chgp": "-96.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2,882.90",
          "val2": "-2,644.30",
          "chgp": "-9.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Apr'25 - YoY

Apr'25

Apr'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-1,005.40

-664.10

-51.39%

Interest

7.30

5.30

37.74%

Exceptional Items

0.00

Consolidate Net Profit

-1,531.50

-144.80

-957.67%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Apr 2025 is 0.00% vs 0.00% in Apr 2024

Consolidated Net Profit

YoY Growth in quarter ended Apr 2025 is -957.67% vs 76.88% in Apr 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Jan'25

Jan'25

Jan'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-3,506.70

-4,525.20

22.51%

Interest

18.90

25.80

-26.74%

Exceptional Items

9.30

252.30

-96.31%

Consolidate Net Profit

-2,882.90

-2,644.30

-9.02%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Jan 2025 is 0.00% vs 0.00% in Jan 2024

Consolidated Net Profit

YoY Growth in year ended Jan 2025 is -9.02% vs 52.44% in Jan 2024

All Annual Results

Company CV

About SanBio Co., Ltd.

SanBio Co., Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available